Is there substantial evidence to support once-daily dosing of IV gentamicin in patients with endocarditis?

No direct evidence for the exclusive efficacy of once-daily IV gentamicin in endocarditis exists. Indirect studies suggest it might offer safety benefits over traditional regimens, but direct evidence specific to endocarditis remains limited.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24309705
Primary Topic
Infective Endocarditis Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Is there substantial evidence to support once-daily dosing of IV gentamicin in patients with endocarditis?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Infective Endocarditis Diagnosis and Management
article

Is there substantial evidence to support once-daily dosing of IV gentamicin in patients with endocarditis?

Tripdatabase
article en

Abstract

No direct evidence for the exclusive efficacy of once-daily IV gentamicin in endocarditis exists. Indirect studies suggest it might offer safety benefits over traditional regimens, but direct evidence specific to endocarditis remains limited.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Infective Endocarditis Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon